Nika Pharmaceuticals, Inc. (NIKA)

Nika Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	0.09	0.06	0.18	0.01	0.01
Research & Development	-	-	3	-	-
Operating Expenses	0.09	0.06	3.18	0.01	0.01
Operating Income	-0.09	-0.06	-3.18	-0.01	-0.01
Pretax Income	-0.09	-0.06	-3.18	-0.01	-0.01
Net Income	-0.09	-0.06	-3.18	-0.01	-0.01
Net Income to Common	-0.09	-0.06	-3.18	-0.01	-0.01
Shares Outstanding (Basic)	983	876	724	396	396
Shares Outstanding (Diluted)	983	876	724	396	396
Shares Change (YoY)	3.03%	21.01%	82.77%	-	-
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.13	-0.06	-0.03	-0.01	-0.01
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
EBIT	-0.09	-0.06	-3.18	-0.01	-0.01

Source: S&P Capital IQ. Standard template. Financial Sources.